Popular

• 

  RestartResume

  Earlier Action, Lasting Impact: Closing the LDL-C Gap in Patients Without a Prior MACE

  CME/CE

  Earlier Action, Lasting Impact: Closing the LDL-C Gap in Patients Without a Prior MACE

  • 

    

    Erin Bohula, MD, DPhil

    Peer

  • 

    

    Lawrence Leiter

    Peer

  0.25 credits

• 

  RestartResume

  uACR and eGFR: A Dual-Marker Approach to Cardiovascular Risk Assessment

  Conversations in CV Risk Assessment

  uACR and eGFR: A Dual-Marker Approach to Cardiovascular Risk Assessment

  • 

    

    Matthew Sorrentino, MD

    Peer

  • 

    

    Ashish Verma, MD

    Peer

• 

  RestartResume

  Rethinking Chronic Kidney Disease: A Key Driver of Cardiovascular Risk

  Conversations in CV Risk Assessment

  Rethinking Chronic Kidney Disease: A Key Driver of Cardiovascular Risk

  • 

    

    Jennifer Caudle, DO

    Peer

  • 

    

    Dustin Le, MD, MHS

    Peer

  • 

    

    Niloofar Nobakht, MD, FASN

    Peer

• 

  RestartResume

  The Role of Albuminuria in Assessing Cardiovascular Risk

  Conversations in CV Risk Assessment

  The Role of Albuminuria in Assessing Cardiovascular Risk

  • 

    

    Brian P. McDonough, MD, FAAFP

    Peer

  • 

    

    Anu Lala, MD

    Peer

• 

  RestartResume

  "I think we're the bridge between the healthcare systems, the pharma systems, and the molecular diagnostic systems," says Matt Newman with Manifold

  The Convergence

  "I think we're the bridge between the healthcare systems, the pharma systems, and the molecular diagnostic systems," says Matt Newman with Manifold

  • 

    

    Brian P. McDonough, MD, FAAFP

    Peer

  • 

    

    Matthew Newman

    Peer

• 

  RestartResume

  IgAN Management Into Practice: Evolving Guidelines & Targeted Therapies

  CME/CE

  IgAN Management Into Practice: Evolving Guidelines & Targeted Therapies

  • 

    

    Jörg Latus, MD

    Peer

  • 

    

    Jürgen Floege, MD

    Peer

  0.25 credits

• 

  RestartResume

  Evidence Builds for Cell-Based Influenza Vaccines

  Medical Industry Feature

  Evidence Builds for Cell-Based Influenza Vaccines

  • 

    

    Jennifer Caudle, DO

    Peer

  • 

    

    Wendy Wright, DNP, FNP-BC, ANP-BC

    Peer

• 

  RestartResume

  Albuminuria: An Overlooked Red Flag in Cardiovascular Risk

  Conversations in CV Risk Assessment

  Albuminuria: An Overlooked Red Flag in Cardiovascular Risk

  • 

    

    Matthew Sorrentino, MD

    Peer

  • 

    

    Ashish Verma, MBBS

    Peer

• 

  RestartResume

  The Fifth Pillar? Closing the Gap in HFrEF

  CME/CE

  The Fifth Pillar? Closing the Gap in HFrEF

  • 

    

    Carolyn S. P. Lam, MBBS, PhD, MRCP, MS, FACC, FAMS, FESC

    Peer

  • 

    

    Javed Butler, MD

    Peer

  • 

    

    Stephen J. Greene, MD, FACC, FHFSA

    Peer

  0.50 credits

• 

  RestartResume

  The Overlooked Valve: Why Women With Aortic Stenosis Fall Through the Cracks

  Cardiology

  The Overlooked Valve: Why Women With Aortic Stenosis Fall Through the Cracks

  • 

    

    Pam R. Taub, MD, FACC, FASPC

    Peer

• 

  RestartResume

  Rethinking Schizophrenia Treatment Through Muscarinic Modulation

  CME/CE

  Rethinking Schizophrenia Treatment Through Muscarinic Modulation

  • 

    

    Jose Rubio, MD

    Peer

  • 

    

    Jonathan M. Meyer

    Peer

  0.25 credits

• 

  RestartResume

  An Expert’s Approach to a Difficult-to-Manage Condition: Breaking the rCDI Cycle with a Microbiome-Focused Strategy

  Medical Industry Feature

  An Expert’s Approach to a Difficult-to-Manage Condition: Breaking the rCDI Cycle with a Microbiome-Focused Strategy

  • 

    

    Paul Feuerstadt, MD, FACG, AGAF

    Peer

• 

  RestartResume

  Timely Surgery for Hip Fractures: Addressing Anticoagulant Challenges

  Clinician's Roundtable

  Timely Surgery for Hip Fractures: Addressing Anticoagulant Challenges

  • 

    

    Steve Jackson, PharmD

    Peer

  • 

    

    Anna Miller, MD

    Peer

  • 

    

    Michael Weaver, MD

    Peer

• 

  RestartResume

  Recognizing Methamphetamine-Associated PAH: Strategies for Complex Care

  Deep Breaths: Updates from CHEST

  Recognizing Methamphetamine-Associated PAH: Strategies for Complex Care

  • 

    

    Rodolfo A. Estrada MD, FCCP

    Peer

  • 

    

    Steven M. Hollenberg, MD

    Peer

  • 

    

    Dana Kay, DO

    Peer

• 

  RestartResume

  Beyond the Scalpel: When TGCT Surgery Isn’t the Solution

  MinuteCE®

  Beyond the Scalpel: When TGCT Surgery Isn’t the Solution

  • 

    

    Michiel van de Sande, MD, PhD

    Peer

  1.00 program credits